Synopsis
0
JDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Parenteral
Topical
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
59
PharmaCompass offers a list of Xylometazoline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Xylometazoline Hydrochloride manufacturer or Xylometazoline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Xylometazoline Hydrochloride manufacturer or Xylometazoline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Xylometazoline Hydrochloride API Price utilized in the formulation of products. Xylometazoline Hydrochloride API Price is not always fixed or binding as the Xylometazoline Hydrochloride Price is obtained through a variety of data sources. The Xylometazoline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imidin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imidin, including repackagers and relabelers. The FDA regulates Imidin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imidin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imidin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imidin supplier is an individual or a company that provides Imidin active pharmaceutical ingredient (API) or Imidin finished formulations upon request. The Imidin suppliers may include Imidin API manufacturers, exporters, distributors and traders.
click here to find a list of Imidin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imidin DMF (Drug Master File) is a document detailing the whole manufacturing process of Imidin active pharmaceutical ingredient (API) in detail. Different forms of Imidin DMFs exist exist since differing nations have different regulations, such as Imidin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imidin DMF submitted to regulatory agencies in the US is known as a USDMF. Imidin USDMF includes data on Imidin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imidin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imidin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Imidin Drug Master File in Korea (Imidin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imidin. The MFDS reviews the Imidin KDMF as part of the drug registration process and uses the information provided in the Imidin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Imidin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imidin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Imidin suppliers with KDMF on PharmaCompass.
A Imidin CEP of the European Pharmacopoeia monograph is often referred to as a Imidin Certificate of Suitability (COS). The purpose of a Imidin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Imidin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Imidin to their clients by showing that a Imidin CEP has been issued for it. The manufacturer submits a Imidin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Imidin CEP holder for the record. Additionally, the data presented in the Imidin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Imidin DMF.
A Imidin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Imidin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Imidin suppliers with CEP (COS) on PharmaCompass.
A Imidin written confirmation (Imidin WC) is an official document issued by a regulatory agency to a Imidin manufacturer, verifying that the manufacturing facility of a Imidin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Imidin APIs or Imidin finished pharmaceutical products to another nation, regulatory agencies frequently require a Imidin WC (written confirmation) as part of the regulatory process.
click here to find a list of Imidin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imidin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imidin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imidin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imidin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imidin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imidin suppliers with NDC on PharmaCompass.
Imidin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imidin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imidin GMP manufacturer or Imidin GMP API supplier for your needs.
A Imidin CoA (Certificate of Analysis) is a formal document that attests to Imidin's compliance with Imidin specifications and serves as a tool for batch-level quality control.
Imidin CoA mostly includes findings from lab analyses of a specific batch. For each Imidin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imidin may be tested according to a variety of international standards, such as European Pharmacopoeia (Imidin EP), Imidin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imidin USP).
